Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
21 Nov 2022 |
CS01 |
Confirmation statement made on 14 November 2022 with no updates
|
|
|
06 Oct 2022 |
AA |
Total exemption full accounts made up to 30 March 2022
|
|
|
08 Dec 2021 |
AP01 |
Appointment of Mr Michael James Murphy as a director on 3 December 2021
|
|
|
08 Dec 2021 |
TM01 |
Termination of appointment of Jonathan Simon Milner as a director on 3 December 2021
|
|
|
07 Dec 2021 |
CH01 |
Director's details changed for Dr Michael Leith Anstey on 1 December 2021
|
|
|
07 Dec 2021 |
CH01 |
Director's details changed for Mr Jason Alexander Mellad on 2 December 2021
|
|
|
15 Nov 2021 |
CS01 |
Confirmation statement made on 14 November 2021 with no updates
|
|
|
28 Jul 2021 |
AA |
Total exemption full accounts made up to 30 March 2021
|
|
|
26 Jan 2021 |
AD01 |
Registered office address changed from Cambridge Biomedical Innovation Hub Clifford Allbutt Building Hills Road Cambridge CB2 0AH England to C/O Milner Therapeutics Institute Jeffrey Cheah Biomedical Centre Puddicombe Way Cambridge Cambridgeshire CB2 0AW on 26 January 2021
|
|
|
18 Dec 2020 |
CS01 |
Confirmation statement made on 14 November 2020 with no updates
|
|
|
17 Jul 2020 |
AA |
Total exemption full accounts made up to 30 March 2020
|
|
|
29 Nov 2019 |
AA01 |
Current accounting period extended from 30 November 2019 to 30 March 2020
|
|
|
18 Nov 2019 |
CS01 |
Confirmation statement made on 14 November 2019 with updates
|
|
|
24 Oct 2019 |
CH03 |
Secretary's details changed for Mr Daniel Edward Rooke on 24 October 2019
|
|
|
01 Jul 2019 |
MR01 |
Registration of charge 116801520001, created on 20 June 2019
|
|
|
20 May 2019 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
07 May 2019 |
RESOLUTIONS |
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
18 Apr 2019 |
AP01 |
Appointment of Joanne Parfrey as a director on 15 April 2019
|
|
|
17 Apr 2019 |
AP01 |
Appointment of Dr Ian Tomlinson as a director on 15 April 2019
|
|
|
16 Apr 2019 |
SH01 |
Statement of capital following an allotment of shares on 15 April 2019
|
|
|
16 Apr 2019 |
PSC01 |
Notification of Jonathan Simon Milner as a person with significant control on 15 April 2019
|
|
|
16 Apr 2019 |
PSC02 |
Notification of Babraham Bioscience Technologies Limited as a person with significant control on 15 April 2019
|
|
|
16 Apr 2019 |
PSC02 |
Notification of Cambridge Innovation Capital Plc as a person with significant control on 15 April 2019
|
|
|
16 Apr 2019 |
AP01 |
Appointment of Dr Jonathan Simon Milner as a director on 15 April 2019
|
|
|
16 Apr 2019 |
AP01 |
Appointment of Dr Michael Leith Anstey as a director on 15 April 2019
|
|